DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20171266

Retracted: Risk of cardiovascular disease among diabetic patients in rural population of Central India

Prem S. Singh, K. S. Zafar, Manoj Kumar, Sudhir K. Yadav

Abstract


The article titled “Risk of cardiovascular disease among diabetic patients in rural population of Central India” by Singh PS published in International Journal of Research in Medical Sciences 2017;5(4):1563-70, DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20171266 is retracted.

After the publication of the above article, one of the publishers reported that a large part of the text is plagiarized from a similar article published in Journal of Anthropology, Volume 2014, Article ID 421439, 9 pages, http://dx.doi.org/10.1155/2014/421439 (Mary Grace Tungdim, T. Ginzaniang, G. Poufullung Kabui, Deepali Verma, Satwanti Kapoor. Risk of Cardiovascular Disease among Diabetic Patients in Manipur, Northeast India). We contacted the author who could not satisfactorily respond to our queries. Since the author could not satisfactorily defend his paper and contravened the declaration he made while submitting his manuscript, it was decided to retract the article from International Journal of Research in Medical Sciences and not to consider any manuscript submitted by him in future.


Keywords


Cardiovascular risk, Coronary artery disease, Diabetes

Full Text:

PDF

References


Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229-34.

Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. AHA scientific statement, diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134-46.

Lloyd-Jones DM, Wilson PW, Larson MG, Beiser A, Leip EP, D'Agostino RB, et al. Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol. 2004;94(1):20-4.

Grundy SM, Balady GJ, Criqui MH, Fletcher G, Greenland P, Hiratzka LF, et al. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA task force on risk reduction. American Heart Association. Circulation. 1998;97(18):1876-87.

Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;2(11):987-1003.

Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007;297(6):611-9.

Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ. 2008;336(7659):1475-82.

Beswick A, Brindle P. Risk scoring in the assessment of cardiovascular risk. Curr Opin Lipidol. 2006;17(4):375-86.

Census of India, Provisional population table, 2011, American Diabetes Association, Standards of medical care in diabetes. Diabetes Care. 2005;28(1):5-36.

Weiner JS, Lourie JA, eds. Practical human biology. London: Academic Press; 1981.

World Health Organization. Diet, Nutrition and the Prevention of Chronic Disease: Report of a Joint WHO/FAO Expert Consultation. Geneva, Switzerland: World Health Organization. WHO Technical Report Series; 2003:916.

Ashwell OBE M. Waist to height ratio and the Ashwell shape chart to predict the health risks of obesity in adults and children in all ethnic groups. The Journal of Nutrition and Food Science. 2005;35(5):359-64.

Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves JW, Hill MN, et al. Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. The Journal of Clinical Hypertension. 2005;7(2):102-9.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560-71.

American Diabetes Association. Standards of medical care in diabetes- 2012. Diabetes Care. 2012;35:S11-63.

D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care. Circulation. 2008;117(6):743-53.

Gomes MB, Giannella-Neto D, Faria M, Tambascia M, Fonseca RM, Rea R, et al. Estimating cardiovascular risk in patients with type 2 diabetes: a national multicenter study in Brazil. Diabetol Metabol Syndrome. 2009;1(1):22-8.

Lee WL, Cheung AM, Cape D, Zinman B. Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care. 2000;23(7):962-8.

Hu G, Jousilahti P, Qiao Q, Katoh S, Tuomilehto J. Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction. Diabetol. 2005;48(5):856-61.

Steinberg HO, Paradisi G, Cronin J, Crowde K, Hempfling A, Hook G, et al. Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation. 2000;101(17):2040-6.

Juutilainen A, Kortelainen S, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care. 2004 ;27(12):2898-904.

Kanaya AM, Grady D, Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Archives of Internal Med. 2002;162(15):1737-45.

Laakso M. Cardiovascular disease in type 2 diabetes from population to man to mechanisms. Diabetes Care. 2010;33(2):442-9.

UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The lancet. 1998;352(9131):837-53.

Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, et el. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. The Lancet. 2005;366(9493):1279-89.

Mannucci E, Monami M, Lamanna C, Gori F, Marchionni N. Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials. Nutrition, Metabolism and Cardiovascular Diseases. 2009;19(9):604-12.

ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;2008(358):2560-72.

Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;2008(358):2545-59.

Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. New England J Med. 2009;360(2):129-39.

Ahmad Kiadaliri A, Clarke PM, Gerdtham UG, Nilsson P, Eliasson B, Gudbjörnsdottir S, et al. Predicting changes in cardiovascular risk factors in type 2 diabetes in the post-UKPDS era: longitudinal analysis of the Swedish National Diabetes Register. J Diabetes Res. 2013;2013(55)1050-6.

Chiu JF, Bell AD, Herman RJ, Hill MD, Stewart JA, Cohen EA, et al. Cardiovascular risk profiles and outcomes of Chinese living inside and outside China. European J Cardio Prev Rehabilit. 2010;17(6):668-75.

Dhall M, Gupta S, Bhuker M, Sharma P, Kapoor S. Effectiveness of various anthropometric indices in prediction of cardiovascular risk among adult Jains. The Open Anthropology Journal. 2011;4(13):33-9.

Czernichow S, Kengne AP, Huxley RR, Batty GD, De Galan B, Grobbee D, et al. Comparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk in people with type-2 diabetes: a prospective cohort study from ADVANCE. European Journal of Cardiovascular Prevention Rehabilitation. 2011;5(2):312-9.

Bhasin P, Kapoor S. Pregnancy complications and calculated cardiovascular risk in urban women: do we envisage an association? Journal of Urban Health. 2014;91(1):162-75.

Stamler J, Vaccaro O, Neaton JD, Wentworth D, Multiple risk factor intervention trial research group. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16(2):434-44.

Smith SC Jr. Multiple risk factors for cardiovascular disease and diabetes mellitus. Am J Med. 2007;120(3 Suppl 1):S3-11.

Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values: Am J Clin Nut. 2002;76(45):50-6.

Levitan EB, Mittleman MA, Håkansson N, Wolk A. Dietary glycemic index, dietary glycemic load, and cardiovascular disease in middle-aged and older Swedish men. Am J Clin Nutr. 2007;85(6):1521-6.

Key TJ, Fraser GE, Thorogood M, Appleby PN, Beral V, Reeves G, et al. Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies. The Am J Clin Nutrit. 1999;70(3):516-24.

Chakraborty R, Dey S, Dkhar P, Thabah C, Rynjah W. Diabetics of Northeast India are at risk of dietary Zinc and Manganese deficiency: Possible improvement through consumption of some traditional edibles or edibles of limited popularity. Internat J Diab Develop Countries. 2010;30(4):201-7.

Anetor JI, Senjobi A, Agbedana EO, Ajose OA. Decreased serum magnesium and zinc levels: atherogenic implications in type-2 diabetes mellitus in Nigerians. Nutrition and health. 2002;16(4):291-300.

Watkins PJ. ABC of diabetes: cardiovascular disease, hypertension, and lipids. British Med J. 2003;326(7394):874-6.

Laakso M. Epidemiology of macrovascular disease in diabetes. Diabetes Rev. 1997;5(20)294-315.

Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes. JAMA. 1990;263(21):2893-900.

Eddy D, Schlessinger L, Kahn R, Peskin B, Schiebinger R. Relationship of insulin resistance and related metabolic variables to coronary artery disease: a mathematical analysis. Diabetes Care. 2009;32(2):361-6.

Laakso M. Cardiovascular disease in type 2 diabetes from population to man to mechanisms. Diabetes Care. 2010;33(2):442-9.

UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet. 1998;352(9131):837-53.

Anetor JI, Senjobi A, Agbedana EO, Ajose OA. Decreased serum magnesium and zinc levels: atherogenic implications in type-2 diabetes mellitus in Nigerians. Nutrition Health. 2002;16(4):291-300.

Watkins PJ. ABC of diabetes: cardiovascular disease, hypertension and lipids. British Med J. 2003;326(7394):874-6.